Other variables, including sex, age ≥ 70 years, and comorbid conditions such as coronary artery disease, diabetes mellitus, and peripheral artery disease, and type of care setting did not reach statistical significance.
← all excerpts
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.
1
—
—